Company
Nuvation Bio Inc. (NUVB)
Standardized SEC financial data for Nuvation Bio Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001811063 · NYSE · Pharmaceutical Preparations.
Gross margin
1.3%
Operating margin
-338.7%
Net margin
-325.3%
Revenue growth (YoY)
699.0%
Return on equity
-66.9%
ROIC
-89.1%
Free cash flow
-$181.4M
Debt / equity
0.15×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $7.9M | $62.9M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $29.8M | $132.4M | $101.1M | $42.6M | $35.7M | $164.1M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$36.5M | -$68.2M | -$96.1M | -$68.0M | -$130.4M | -$173.4M |
| Capital expenditures |
Get NUVB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NUVB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NUVB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"